Skip to main content

DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival

Publication ,  Conference
Klempner, SJ; Bendell, JC; Villaflor, VM; Tenner, LL; Stein, S; Naik, GS; Sirard, CA; Kagey, M; Chaney, MF; Strickler, JH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Klempner, S. J., Bendell, J. C., Villaflor, V. M., Tenner, L. L., Stein, S., Naik, G. S., … Strickler, J. H. (2020). DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Klempner, Samuel J., Johanna C. Bendell, Victoria Meucci Villaflor, Laura LaNiel Tenner, Stacey Stein, Girish S. Naik, Cynthia A. Sirard, Michael Kagey, Marya F. Chaney, and John H. Strickler. “DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein S, Naik GS, et al. DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein S, Naik GS, Sirard CA, Kagey M, Chaney MF, Strickler JH. DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences